Silo Pharma (SILO) Short term Debt (2021 - 2023)
Silo Pharma (SILO) posted Short term Debt of $660279.0 for Q1 2023, up 81.29% sequentially from $364216.0 in Q4 2022, and up 918.34% YoY from $64839.0 in Q1 2022.
Silo Pharma (SILO) Short term Debt (2021 - 2023) Analysis & Trends
Silo Pharma has reported Short term Debt for 3 years, with the latest figure at $660279.0 in Q1 2023.
- Quarterly Short term Debt rose 918.34% year-over-year to $660279.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $660279.0 (up 918.34% YoY) and the FY2022 annual result came in at $364216.0, down 12.85% from the prior year.
- Short term Debt climbed to $660279.0 in Q1 2023 per SILO's latest filing, from $364216.0 in the prior quarter.
- Over five years, Short term Debt peaked at $660279.0 in Q1 2023 and troughed at $2366.0 in Q1 2021.
- A 3-year average of $190123.1 and a median of $72102.0 in 2021 frame the typical range for Short term Debt.
- The widest YoY moves for Short term Debt: up 2640.45% in 2022, down 77.19% in 2022.
- Over 3 years, Short term Debt stood at $417937.0 in 2021, then slipped by 12.85% to $364216.0 in 2022, then soared by 81.29% to $660279.0 in 2023.
- According to Business Quant data, Short term Debt over the past three periods registered $660279.0, $364216.0, and $16447.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 660,279.00 |
| Dec 31, 2022 | 364,216.00 |
| Sep 30, 2022 | 16,447.00 |
| Jun 30, 2022 | 40,819.00 |
| Mar 31, 2022 | 64,839.00 |
| Dec 31, 2021 | 417,937.00 |
| Sep 30, 2021 | 72,103.00 |
| Jun 30, 2021 | 72,102.00 |
| Mar 31, 2021 | 2,366.00 |